2 completed, 2 recruiting, 1 withdrawn. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Recruiting 2, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow High Blood Pressure: new trials by email Literature Review of High Blood Pressure trials Research Report on High Blood Pressure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) Losartan, Amlodipine, Placebo - Coarctation of Aorta, High Blood Pressure | Phase 3 | Recruiting | Mayo Clinic | 120 | 2024-04-01 | 2026-09-11 |
| Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Oral Nifedipine, Oral Labetalol - Postpartum Complication, Maternal Hypertension | Phase 3 | Recruiting | Loma Linda University | 500 | 2023-05-08 | 2026-02-04 |
| Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) Low-dose rtPA, Standard-dose rtPA, Intensive blood pressure (BP) lowering - Ischemic Stroke, High Blood Pressure | Phase 3 | Completed | The George Institute | 4587 | 2012-03-01 | 2021-10-13 |
| Safety Study of Nebivolol for COPD Patients Placebo, Nebivolol - High Blood Pressure | Phase 2 / Phase 3 | Withdrawn | University of Chicago | 2012-01-01 | 2016-01-12 | |
| The Health Outcomes Management and Evaluation (HOME) Study Care team - Diabetes, Hyperlipidemia | Phase 3 | Completed | Emory University | 447 | 2010-04-01 | 2016-02-26 |
Hypertension (5) · Aortic Coarctation (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Hyperlipidemias (1) · Hypertension, Pregnancy-Induced (1) · Ischemic Stroke (1) · Pulmonary Disease, Chronic Obstructive (1)
Cardiovascular Diseases (5) · Vascular Diseases (5) · Brain Diseases (1) · Cardiovascular Abnormalities (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Chronic Disease (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Dyslipidemias (1) · Endocrine System Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Heart Defects, Congenital (1)
Labetalol (2) · Amlodipine (1) · Clonidine (1) · Enalaprilat (1) · Hydralazine (1) · Losartan (1) · Metoprolol (1) · Nebivolol (1) · Nicardipine (1) · Nifedipine (1) · Nitroglycerin (1) · Phentolamine (1) · Tissue Plasminogen Activator (1) · esmolol (1) · urapidil (1)
Emory University (1) · Loma Linda University (1) · Mayo Clinic (1) · The George Institute (1) · University of Chicago (1)
United States (4) · Australia (1)
Alexander Egbe, MBBS, MPH (1) · Benjamin G Druss, MD MPH (1) · Craig S Anderson, MD (1) · George Bakris, MD (1)
PMID 27161018, PMID 28619989, PMID 28739832, PMID 28973174, PMID 29185557, PMID 29402064, PMID 29571842, PMID 29777016, PMID 30266885, PMID 30739745, PMID 30760277, PMID 30961463, PMID 31812956, PMID 31822251, PMID 31969072, PMID 32568636, PMID 32640944, PMID 33031175, PMID 33069172, PMID 33526633, PMID 33536271, PMID 34096413, PMID 34702064, PMID 36820100, PMID 36939933, PMID 39258531, PMID 39541551, PMID 40177745, PMID 41131698, PMID 41192975, PMID 42644244
R01HL162830 (1), R01MH070437 (1)